Gadolinium-based MR contrast agents and nephrogenic systemic fibrosis

Radiology. 2007 Mar;242(3):647-9. doi: 10.1148/radiol.2423061640. Epub 2007 Jan 9.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Clinical Trials as Topic
  • Contrast Media / adverse effects*
  • Evidence-Based Medicine
  • Fibrosis
  • Gadolinium / adverse effects*
  • Humans
  • Incidence
  • Kidney Failure, Chronic / chemically induced*
  • Kidney Failure, Chronic / epidemiology
  • Magnetic Resonance Imaging / adverse effects*
  • Magnetic Resonance Imaging / statistics & numerical data
  • Risk Assessment / methods*
  • Risk Factors
  • Skin / pathology*
  • Skin Diseases / chemically induced*
  • Skin Diseases / epidemiology

Substances

  • Contrast Media
  • Gadolinium